Biomerica annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
2026
Biomerica Debt-to-Equity Ratio Growth & History (BMRA)
Biomerica's debt-to-equity ratio was 0.72 for fiscal 2026.
View full Biomerica company overviewBiomerica annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-05-31 | 0.72 | 0.60 | +541.72% |
| 2025 | 2025-05-31 | 0.11 | −0.01 | −6.32% |
| 2024 | 2024-05-31 | 0.12 | 0.03 | +29.05% |
| 2023 | 2023-05-31 | 0.09 | −0.07 | −44.33% |
| 2022 | 2022-05-31 | 0.17 | −0.01 | −5.55% |
| 2021 | 2021-05-31 | 0.18 | 0.05 | +40.02% |
| 2020 | 2020-05-31 | 0.13 | — | — |
Biomerica quarterly debt-to-equity ratio
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-05-31 | 0.72 | 0.60 | +541.72% |
| Q3 2026 | 2026-02-28 | 0.06 | −0.04 | −40.70% |
| Q2 2026 | 2025-11-30 | 0.06 | −0.06 | −47.69% |
| Q1 2026 | 2025-08-31 | 0.07 | −0.06 | −45.29% |
| Q4 2025 | 2025-05-31 | 0.11 | −0.01 | −6.32% |
| Q3 2025 | 2025-02-28 | 0.10 | −0.01 | −11.12% |
| Q2 2025 | 2024-11-30 | 0.12 | 0.02 | +22.58% |
| Q1 2025 | 2024-08-31 | 0.13 | 0.04 | +40.86% |
| Q4 2024 | 2024-05-31 | 0.12 | 0.03 | +29.05% |
| Q3 2024 | 2024-02-29 | 0.11 | −0.09 | −43.88% |
| Q2 2024 | 2023-11-30 | 0.10 | −0.07 | −42.04% |
| Q1 2024 | 2023-08-31 | 0.09 | −0.06 | −40.58% |
| Q4 2023 | 2023-05-31 | 0.09 | −0.07 | −44.33% |
| Q3 2023 | 2023-02-28 | 0.20 | 0.05 | +33.03% |
| Q2 2023 | 2022-11-30 | 0.17 | 0.00 | +2.10% |
| Q1 2023 | 2022-08-31 | 0.16 | −0.02 | −11.05% |
| Q4 2022 | 2022-05-31 | 0.17 | −0.01 | −5.55% |
| Q3 2022 | 2022-02-28 | 0.15 | −0.01 | −3.55% |
| Q2 2022 | 2021-11-30 | 0.17 | 0.02 | +12.06% |
| Q1 2022 | 2021-08-31 | 0.18 | 0.04 | +29.07% |
| Q4 2021 | 2021-05-31 | 0.18 | 0.05 | +40.02% |
| Q3 2021 | 2021-02-28 | 0.15 | −0.24 | −60.79% |
| Q2 2021 | 2020-11-30 | 0.15 | −0.41 | −72.94% |
| Q1 2021 | 2020-08-31 | 0.14 | −0.39 | −74.11% |
| Q4 2020 | 2020-05-31 | 0.13 | — | — |
| Q3 2020 | 2020-02-29 | 0.39 | — | — |
| Q2 2020 | 2019-11-30 | 0.56 | — | — |
| Q1 2020 | 2019-08-31 | 0.53 | — | — |
Biomerica debt-to-equity ratio trends
Over the last five fiscal years, Biomerica's debt-to-equity ratio increased from 0.18 to 0.72, a change of 0.54. The latest reported quarter, Q4 2026, shows 0.72.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biomerica source filings ↗